Nanoplatelets modified with RVG for targeted delivery of miR-375 and temozolomide to enhance gliomas therapy

Nanoplatelets modified with RVG for targeted delivery of miR-375 and temozolomide to enhance gliomas therapy

Abstract Gliomas are one of the most frequent primary brain tumors and pose a serious threat to people’s lives and health. Platelets, a crucial component of blood, have been applied as drug delivery carriers for disease diagnosis and treatment. In this study, we designed engineered nanoplatelets for...

Full description

Bibliographic Details
Main Authors: Tingting Yang, Nan Zhang, Yuanyuan Liu, Ruyue Yang, Zhaoyi Wei, Futai Liu, Dan Song, Longwei Wang, Jiangyan Wei, Yuanpei Li, Deliang Shen, Gaofeng Liang
Format: Article
Language:English
Published: BMC 2024-10-01
Series:Journal of Nanobiotechnology
Subjects:
Nanoplatelets
Targeted drug delivery
TMZ
MiR-375
Gliomas
Online Access:https://doi.org/10.1186/s12951-024-02895-6

Internet

https://doi.org/10.1186/s12951-024-02895-6

Similar Items